The DOI matches its Crossref record.
Growth Hormone Secretory Dynamics in Streptozotocin Diabetes: Evidence of a Role for Endogenous Circulating Somatostatin*
Abstract
The present studies examined the effects of streptozotocin-induced diabetes on the dynamics of GH, insulin (IRI), and glucose secretion in 68 chronically cannulated male rats. Animals were rendered diabetic by a single iv injection of streptozotocin (65 mg/kg) and sampled every 15 min for periods of 6h both before and at various times after treatment. The typical ultradian rhythm of GH secretion was evident in normal rats, with most peak GH values greater than 500 ng/ml (mean 6-h GH level, 125.3 ± 17.2 ng/ml). After streptozotocin administration, a significant depression in the amplitude of GH pulses was observed as early as 18 h post treatment (mean 6-h GH level, 54.4 ± 9.4 ng/ml; P < 0.01) concomitant with a marked elevation in plasma glucose levels and severe depression of plasma IRI levels. The amplitude and duration of the GH secretory episodes continued to decline over a 4-week period in the presence of persisting hyperglycemia and mostly undetectable plasma IRI levels. The pituitary GH concentration was not significantly altered 8 days post treatment. To elucidate the mechanism mediating the streptozotocininduced GH suppression response, the role of somatostatin (SRIF) was assessed by passive immunization with a specific SRIF antiserum. Two groups of streptozotocin-diabetic rats were administered iv 1 ml of either SRIF antiserum or normal sheep serum. The GH profiles of diabetic rats administered normal sheep serum continued to show a marked suppression of GH pulses (mean 6-h GH level, 69.5 ±7.8 ng/ml). In striking contrast, the GH profiles of diabetic SRIF antiserum-treated rats revealed a rapid (within 15–30 min) restoration of high amplitude GH pulses (500–800 ng/ml) and a significant elevation of GH trough levels. The mean 6-h GH level in these animals (150.3 ± 16.8 ng/ml) was significantly greater than that in normal sheep serumtreated controls (P < 0.01). In contrast to the effects on GH, no significant differences were observed in plasma glucose and IRI levels of diabetic SRIF antiserum-treated rats compared to diabetic normal sheep serum-treated controls. These results clearly demonstrate that the GH secretory episodes are markedly suppressed in the presence of streptozotocin-induced diabetes. Furthermore, the findings indicate that circulating SRIF plays a role in the GH suppression response observed in streptozotocin diabetes but is not involved in mediating the streptozotocin-induced effects on glucose and IRI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sexual Dimorphism in the Control of Growth Hormone Secretion*
JANSSON, J.-O., EDÉN, S., & ISAKSSON, O. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-2-128 · Cited by 745
Neuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 634
TANNENBAUM, G. S., & LING, N. (1984) · Endocrinology · doi:10.1210/endo-115-5-1952 · Cited by 524
Self-citationHo, K. Y., Veldhuis, J. D., Johnson, M. L., Furlanetto, R., Evans, W. S., Alberti, K. G., & Thorner, M. O. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113450 · Cited by 503
Williams, T., Berelowitz, M., Joffe, S. N., Thorner, M. O., Rivier, J., Vale, W., & Frohman, L. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112203 · Cited by 428
Metadata
- Authors
- TANNENBAUM, G. S.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1981-01
- Volume
- 108
- Issue
- 1
- Pages
- 76-82
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2138737282
- Cited by
- 195
- References
- 0
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Growth Hormone Secretory Dynamics in Streptozotocin Diabetes: Evidence of a Role for Endogenous Circulating Somatostatin*. https://app.cochat.ai/papers/10.1210/endo-108-1-76
- The paper
- TANNENBAUM, G. S. (1981). Growth Hormone Secretory Dynamics in Streptozotocin Diabetes: Evidence of a Role for Endogenous Circulating Somatostatin*. Endocrinology. https://doi.org/10.1210/endo-108-1-76
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.